1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------
Form 8-A/A
(Amendment No. 1)
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
DURAMED PHARMACEUTICALS, INC.
--------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 11-2590026
--------------------------------------- -------------------
(State of incorporation or organization) (I.R.S. Employer
Identification No.)
7155 East Kemper Road, Cincinnati, Ohio 45249
--------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Securities to be registered pursuant to
Section 12(b) of the Act:
None
------------------
Securities to be registered pursuant to Section 12(g) of the Act:
Preferred Stock Purchase Rights
- --------------------------------------------------------------------------------
(Title of Class)
2
Item 1. Description of Securities to be Registered.
-------------------------------------------
On August 12, 1998, the Board of Directors of Duramed Pharmaceuticals,
Inc. (the "Company) amended the Rights Agreement dated as of August 16, 1988,
between the Company and The Provident Bank, as Rights Agent (the "Rights
Agreement") to extend the expiration date for the Preferred Stock Purchase
Rights provided for under the Agreement from August 31, 1998 to August 31, 2008.
Otherwise, the Rights Agreement remains unchanged.
Item 2. Exhibits.
---------
4 Amendment dated as of August 12, 1998 to Rights Agreement
dated as of August 16, 1988 between the Company and The
Provident Bank, as Rights Agent (filed as an exhibit to the
Company's Quarterly Report on Form 10-Q/A (Amendment No. 1)
for the quarter ended June 30, 1998 and incorporated herein by
reference).
SIGNATURE
---------
Pursuant to the requirements of Section 12 of the Securities
Exchange Act of 1934, the registrant has duly caused this amendment to
registration statement to be signed on its behalf by the undersigned, thereto
duly authorized.
DURAMED PHARMACEUTICALS, INC.
Date: August 31, 1998 By: /s/ Timothy J. Holt
-------------------
Timothy J. Holt
Senior Vice President -
Finance and Administration
- 2 -